Lineage-specific early complete donor chimerism and risk of relapse after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia

Recipient–donor chimerism is routinely analyzed after allogeneic hematopoietic stem cell transplantation (HSCT) to monitor engraftment and graft rejection. For malignancies, chimerism can also be used to screen for disease relapse post-HSCT but methodology and interpretation of results are not stand...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindahl, Hannes, Vonlanthen, Sofie, Valentini, Davide, Björklund, Andreas T., Sundin, Mikael, Mielke, Stephan, Hauzenberger, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090632/
https://www.ncbi.nlm.nih.gov/pubmed/35210563
http://dx.doi.org/10.1038/s41409-022-01615-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090632/
https://www.ncbi.nlm.nih.gov/pubmed/35210563
http://dx.doi.org/10.1038/s41409-022-01615-8

Ejemplares similares